Therapy News and Research

RSS

Clinical trials highlight beneficial effect of CRT in heart failure

However, large-scale clinical trials have highlighted the beneficial effect of cardiac resynchronisation therapy (CRT) in the improvement of symptoms and reduction of mortality, and CRT is now recommended in the major European and American guidelines for the treatment and prevention of heart failure.

19 Dec 2011

Baxter receives FDA approval for ADVATE to prevent hemophilia A

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.

From Baxter International Inc. 17 Dec 2011

Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carcinoma

The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.

17 Dec 2011

Researchers discover miR-520 blocks cancer-promoting signaling pathway

MicroRNAs or miRNAs are tiny RNA molecules that have only about 20 nucleotides and do not code for proteins. They regulate many important processes in cells by binding to target messenger RNAs - the instructions for protein production -, thus blocking production of the respective protein. In cancer, the production of some miRNAs is often reduced or amplified. This particularly affects miRNAs that regulate the activity of cancer-promoting genes.

17 Dec 2011

NewYork-Presbyterian/Westchester named 'Planetree Designated Patient-Centered Hospital'

NewYork-Presbyterian Hospital's Westchester Division has been formally named by Planetree Inc. as a "Planetree Designated Patient-Centered Hospital" in recognition of the Hospital's achievement and innovation in the delivery of patient-centered care.

17 Dec 2011

Scientists devise a way to reduce side effects of lung cancer therapy

Scientists may have a way to double the efficacy and reduce the side effects of radiation therapy.

17 Dec 2011

Immediate ART appears preferable to deferring treatment among recently infected HIV patients

Among people recently infected with HIV, immediate antiretroviral therapy (ART) appears preferable to deferring treatment, according to a new study published in The Journal of Infectious Diseases and now available online.

17 Dec 2011

Short spiral-shaped proteins can efficiently deliver DNA segments to cells

Clinical gene therapy may be one step closer, thanks to a new twist on an old class of molecules. A group of University of Illinois researchers, led by professors Jianjun Cheng and Fei Wang, have demonstrated that short spiral-shaped proteins can efficiently deliver DNA segments to cells. The team published its work in the journal Angewandte Chemie.

16 Dec 2011

KCC Director recognized for distinguished contributions to cancer care

Richard Pestell, M.D., Ph.D., FACP, Director of the Kimmel Cancer Center at Jefferson (KCC), has been named a 2011 Fellow of the American Association for the Advancement of Science.

16 Dec 2011

TJC approves UCSD's DSC Certification for Ventricular Assist Device

The Joint Commission (TJC) has approved UC San Diego Health System's Disease-Specific Care (DSC) Certification for Ventricular Assist Device.

16 Dec 2011

IQWiG publishes report on Esbriet benefit assessment for treatment of IPF

InterMune, Inc. today reported that the private Institute for Quality and Efficiency in Health Care (IQWiG) has today published its report on the benefit assessment of Esbriet (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis.

16 Dec 2011

FDA accepts Vertex KALYDECO NDA for six-month Priority Review

Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for KALYDECOTM (ivacaftor) and granted the company's request for six-month Priority Review.

16 Dec 2011

Critical Diagnostics receives FDA clearance for Presage ST2 Assay

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug Administration has cleared the company's Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.

16 Dec 2011

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

15 Dec 2011

RaySearch initiates IMRT European trial to treat rectal cancer

RaySearch Laboratories AB announces that the first patient in Europe has been treated with a treatment plan created with RaySearch's treatment planning system RayStation.

From Elekta 15 Dec 2011

ICRM director-general to give lecture about cancer research in India at AACR conference

Vishwa Mohan Katoch, M.D., will give a special lecture entitled "Cancer Research in India: Future Directions" at the AACR International Conference on New Horizons in Cancer Research: Biology to Prevention to Therapy, Dec. 13-16, 2011, in Gurgaon, Delhi (NCR), India.

15 Dec 2011

Study evaluates use of leukocyte and platelet-rich fibrin biomaterial in heart patients

Cardiac patients that take anticoagulant medications and need a tooth extraction face an increased risk of bleeding that must be addressed by the treating clinician. Therefore, a protocol for heart patients is needed that will avoid significant bleeding after dental extractions without suspending anticoagulant therapy.

15 Dec 2011

Lab results change in consistent ways during the course of Kawasaki disease

Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.

15 Dec 2011

SU2C, MRA announce new Dream Team dedicated to melanoma research

Stand Up To Cancer (SU2C), the Melanoma Research Alliance (MRA) and SU2C's scientific partner, the American Association for Cancer Research (AACR), today announced a new Dream Team dedicated to melanoma research. Jeffrey M. Trent, Ph.D., and Patricia M. LoRusso, D.O., will lead the Dream Team project entitled "Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer."

15 Dec 2011

Cereblon protein now holds hope in fight against multiple myeloma

Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, say Mayo Clinic researchers who presented results of several clinical trials at the 53nd annual meeting of the American Society of Hematology Dec. 10-13 in San Diego.

15 Dec 2011